Natasha S. Clayton
Tyndall Avenue
Bristol, ENG BS81TL, United Kingdom
Bristol, ENG BS81TL, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.
Journal: Cell reports
Published: June 04, 2026
A rapid method of evaluating cytotoxic drug efficacy using sub-cellular fluctuation imaging.
Journal: Scientific reports
Published: May 02, 2025
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells.
Journal: European journal of pharmacology
Published: September 04, 2024
RhoU forms homo-oligomers to regulate cellular responses.
Journal: Journal of cell science
Published: September 13, 2023
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction.
Journal: International journal of molecular sciences
Published: March 06, 2023
Statins change the cytokine profile in Trypanosoma cruzi-infected U937 macrophages and murine cardiac tissue through Rho-associated kinases inhibition.
Journal: Frontiers in immunology
Published: September 02, 2022
Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK.
Journal: The Journal of biological chemistry
Published: March 07, 2022
Targeting Rho GTPase Signaling Networks in Cancer.
Journal: Frontiers in cell and developmental biology
Published: January 15, 2020
Emerging Roles of Fibroblast Growth Factor 10 in Cancer.
Journal: Frontiers in genetics
Published: August 22, 2018
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.
Journal: Cell reports
Published: July 14, 2017
Inhibition of Ral GTPases Using a Stapled Peptide Approach.
Journal: The Journal of biological chemistry
Published: February 05, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026